Ubs Group Ag Gelesis Holdings, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.11 - $0.52 $547 - $2,585
-4,973 Reduced 45.03%
6,070 $0
Q4 2022

Feb 08, 2023
BUY
$0.22 - $0.51 $2,429 - $5,631
11,043 New
11,043 $3,000
Q2 2022

Aug 10, 2022
SELL
N/A
-3,338 Closed
0 $0
Q1 2022

May 16, 2022
BUY
N/A
3,338 New
3,338 $15,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email